Zhao, S.* ; Kieser, A.* ; Li, H.Y.* ; Reinking, H.K.* ; Weickert, P.* ; Euteneuer, S.* ; Yaneva, D.* ; Acampora, A.C.* ; Götz, M.J.* ; Feederle, R. ; Stingele, J.*
A ubiquitin switch controls autocatalytic inactivation of the DNA-protein crosslink repair protease SPRTN.
Nucleic Acids Res. 49, 902-915 (2021)
Repair of covalent DNA-protein crosslinks (DPCs) by the metalloprotease SPRTN prevents genome instability, premature aging and carcinogenesis. SPRTN is specifically activated by DNA structures containing single- and double-stranded features, but degrades the protein components of DPCs promiscuously and independent of amino acid sequence. This lack of specificity is useful to target diverse protein adducts, however, it requires tight control in return, in order to prohibit uncontrolled proteolysis of chromatin proteins. Here, we discover the components and principles of a ubiquitin switch, which negatively regulates SPRTN. We demonstrate that monoubiquitylation is induced in an E3 ligase-independent manner and, in contrast to previous assumptions, does not control chromatin access of the enzyme. Data obtained in cells and in vitro reveal that monoubiquitylation induces inactivation of the enzyme by triggering autocatalytic cleavage in trans while also priming SPRTN for proteasomal degradation in cis. Finally, we show that the deubiquitylating enzyme USP7 antagonizes this negative control of SPRTN in the presence of DPCs.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
2020
HGF-reported in Year
2020
ISSN (print) / ISBN
0305-1048
e-ISSN
1362-4962
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 49,
Issue: 2,
Pages: 902-915
Article Number: ,
Supplement: ,
Series
Publisher
Oxford University Press
Publishing Place
Great Clarendon St, Oxford Ox2 6dp, England
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
CF Monoclonal Antibodies (CF-MAB)
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502210-001
Grants
ERC
Center for Integrated Protein Sciences Munich (CIPSM)
Alfried Krupp Prize for Young University Teachers - Alfried Krupp von Bohlen and Halbach-Stiftung
European Research Council [ERC Starting Grant]
International Max-Planck Research School for Molecular Life Sciences
Peter and Traudl Engelhorn Foundation
LMU-China Scholarship Council Program
Copyright
Erfassungsdatum
2021-02-12